Hoppa till huvudinnehåll

Aspaveli is indicated as monotherapy in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (PNH) who have haemolytic anaemia1

Efficacy

Clinical efficacy
Patient outcomes

Reference

1. Aspaveli (pegcetacoplan) Summary of Product Characteristics 08/2024.

PP-20361
Other sites
expand_less